Laipac and UAE companies to unveil Covid-19 antigen test system

Laipac Technology has entered a partnership with UAE-based companies YAS Pharmaceuticals and Pure Health to launch the world’s first artificial intelligence (AI)-based Covid-19 antigen test system.

The European CE-IVD-approved LooK SPOT AI COVID-19 Antigen Rapid Test System is a smartphone-based diagnostic device. Credit: Cryptographer / Shutterstock.

Laipac Technology has entered a partnership with UAE-based companies YAS Pharmaceuticals and Pure Health to launch the world’s first artificial intelligence (AI)-based Covid-19 antigen test system.

Free Report

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.

by GlobalData

Enter your details here to receive your free Report.

By clicking the Download Free Report button, you accept the terms and conditions and acknowledge that your data will be used as described in the GlobalData privacy policy By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

LooK SPOT AI COVID-19 Antigen Rapid Test System is a European CE-IVD approved smartphone-based diagnostic device with lateral flow immunoassay indicated for the qualitative detection of SARS-CoV-2 nucleocapsid protein in nasal swabs.

Laipac noted that the LooK SPOT AI Ecosystem transforms medical diagnostics, enabling early disease detection with reliable and precise results.

The test uses the nasal sample collected from 1in in the nostril with the help of AI technology and offers real-time test results within five to eight minutes. It has a sensitivity of 97.4% and a specificity of 98.3% in identifying the SARS-CoV-2 virus.

It can also identify the new UK and South African variant of the SARS-CoV-2 virus.

Laipac co-founder and CEO Diego Lai said: “LooK SPOT’s AI Algorithm has high accuracy and can identify the colour signal on tests in low positive cases when human eyes cannot, therefore, eliminating the human error and manual process done with other antigen tests available in the market.

“LooK SPOT reduces healthcare responders’ cognitive load by providing accurate test results in an easy-to-read format. LooK SPOT has been designed with a tactical edge to fight Covid-19.”

Prior to the test, the LooK COVID-19 antigen cassette can be scanned using the LooK PASS App, which is available for download in Apple or Google stores. The results will be received on smartphones within five to eight minutes.

Furthermore, negative test results provide a QR code on the app, which can be used as a pass to enter a facility, events, and gatherings, or even for transport facilities.

Though Pure Health, LooK SPOT could offer a full API integration with multiple IT and travel applications for real-time reporting.